A predominantly clonal multi-institutional outbreak of Clostridium difficile - Associated diarrhea with high morbidity and mortality

New England Journal of Medicine

Volumn 353, Issue 23, 2005, Pages 2442-2449

  Loo, Vivian G ^a,b   Poirier, Louise ^c,d   Miller, Mark A ^b,e   Oughton, Matthew ^b   Libman, Michael D ^a,b,f   Michaud, Sophie ^j,k   Bourgault, Anne Marie ^d,g   Nguyen, Tuyen ⁱ   Frenette, Charles ^k,l   Kelly, Mirabelle ^h   Vibien, Anne ^m   Brassard, Paul ^a,b   Fenn, Susan ^a   Dewar, Ken ^a,b   Hudson, Thomas J ^a,b   Horn, Ruth ^a,b   René, Pierre ^a,b   Monczak, Yury ^b,e   Dascal, André ^b,e  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f ST MARY S HOSPITAL   (Canada)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h Hôpital Jean Talon   (Canada)

ⁱ Cite de la Sante de Laval   (Canada)

^j CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^k UNIVERSITÉ DE SHERBROOKE   (Canada)

^l HÔPITAL CHARLES LEMOYNE   (Canada)

^m Hôpital Charles LeMoyne ^*  (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM TOXIN; GATIFLOXACIN; LEVOFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIARRHEA; EPIDEMIC; FEMALE; GENE DELETION; GENE EXPRESSION; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BACTERIAL TOXINS; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; GENE DELETION; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; QUEBEC; REPRESSOR PROTEINS; RISK FACTORS;

EID: 28844441314     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa051639     Document Type: Article

References (32)

1. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: a French multicenter study. Arch Intern Med 1996;156:1449-54.
2. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998;26:1027-36.
3. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995;169:480-3.
4. Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum 1995;38:350-4.
5. Poxton IR, McCoubrey J, Blair G. The pathogenicity of Clostridium difficile. Clin Microbiol Infect 2001;7:421-7.
6. Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996;181:29-38.
7. Spigaglia P, Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 2002;40:3470-5.
8. Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988;56:2299-306.
9. Barth H, Aktories K, Popoff MR, Stiles BG. Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 2004;68:373-402.
10. Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466-72.
11. Allen SD, Emery CL, Lyerly DM. Clostridium. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, eds. Manual of clinical microbiology. 8th ed. Vol. 1. Washington, D.C.: American Society of Microbiology Press, 2003:835-56.
12. Fawley WN, Wilcox MH. Pulsed-field gel electrophoresis can yield DNA fingerprints of degradation-susceptible Clostridium difficile strains. J Clin Microbiol 2002;40:3546-7.
13. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
14. Gonçalves C, Decre D, Barbut F, Burghoffer B, Petit JC. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J Clin Microbiol 2004;42:1933-9.
15. Cohen SH, Tang YJ, Silva J Jr. Analysis of the pathogenicity locus in Clostridium difficile strains. J Infect Dis 2000;181:659-63.
16. Clinical and Laboratory Standards Institute (formerly National Committee for Laboratory Standards). Methods for antimicrobial susceptibility testing of anaerobic bacteria. 6th ed. Wayne, Pa.: National Committee for Clinical and Laboratory Standards, 2004. Approved standard document M11-A6.
17. Hyland M, Ofner-Agostini M, Miller M, Paton S, Gourdeau M, Ishak M. Nosocomial Clostridium difficile-associated diarrhea in Canada: results of the Canadian Nosocomial Infection Surveillance Program (CNISP) 1997 N-CDAD Prevalence Surveillance Project. Can J Infect Dis 2001;12:81-8.
18. Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002;23:137-40.
19. Karlström O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. Clin Infect Dis 1998;26:141-5.
20. Warny M, Pépin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-84.
21. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-41.
22. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg 2002;137:1096-100.
23. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an under-appreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72.
24. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273-80.
25. Kyne L, Merry C, O'Connell B, Kelly A, Keane C, O'Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999;28:107-13.
26. Lai KK, Melvin ZS, Menard MJ, Kotilaninen HR, Baker S. Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control. Infect Control Hosp Epidemiol 1997;18:628-32.
27. McCusker ME, Harris AD, Perencevich E, Roghmann MC. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 2003;9:730-3.
28. Gaynes R, Rimland D, Killum E, et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004;38:640-5.
29. Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999;341:1645-51.
30. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996;100:32-40.
31. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-84.
32. Green J, Wintfeld N, Sharkey P, Passman LJ. The importance of severity of illness in assessing hospital mortality. JAMA 1990;263:241-6.